We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

162 hedge funds and large institutions have $873M invested in Momenta Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

368% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $329K

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

31% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 49

1% more funds holding

Funds holding: 160 → 162 (+2)

9% less capital invested

Capital invested by funds: $962M → $873M (-$89.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
64
Reduced
49
Closed
18
Calls
$1.54M
Puts
$329K
Net Calls
+$1.21M
Net Calls Change
-$493K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$137M
2
NI
Numeric Investors
Massachusetts
+$14.4M
3
State Street
State Street
Massachusetts
+$9.05M
4
FCMI
Foresite Capital Management III
California
+$6.74M
5
EDRH
Edmond de Rothschild Holding
Switzerland
+$6.58M

Top Sellers

Rank Fund Capital Flow
1
DCM
Discovery Capital Management
Connecticut
-$22.7M
2
Millennium Management
Millennium Management
New York
-$17.6M
3
O
OrbiMed
New York
-$13.2M
4
SC
Samlyn Capital
New York
-$3.97M
5
SAM
Senzar Asset Management
New York
-$3.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Sectoral Asset Management
Quebec, Canada
$6.14M +$1.27M +80,800 +21%
OM
27
Opaleye Management
Massachusetts
$5.87M +$1.72M +110,000 +33%
FCMI
28
Foresite Capital Management III
California
$5.75M +$6.74M +430,632 New
EDRH
29
Edmond de Rothschild Holding
Switzerland
$5.61M +$6.58M +420,000 New
Ameriprise
30
Ameriprise
Minnesota
$4.56M +$285K +18,174 +6%
SAM
31
Senzar Asset Management
New York
$4.18M -$3.42M -218,602 -41%
PC
32
Pier Capital
Connecticut
$4.13M +$4.84M +309,299 New
Charles Schwab
33
Charles Schwab
California
$3.92M +$689K +43,970 +18%
Renaissance Technologies
34
Renaissance Technologies
New York
$3.72M -$1.86M -118,700 -30%
TAM
35
Tocqueville Asset Management
New York
$3.68M +$173K +11,050 +4%
Morgan Stanley
36
Morgan Stanley
New York
$3.65M +$440K +28,069 +11%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$3.49M +$16 +1 +0%
SDIC
38
South Dakota Investment Council
South Dakota
$3.44M +$1.68M +107,000 +71%
CS
39
Candriam SCA
Luxembourg
$2.8M +$2.19M +140,000 +200%
QI
40
QS Investors
New York
$2.65M -$15.4K -983 -0.5%
Wells Fargo
41
Wells Fargo
California
$2.59M -$257K -16,380 -8%
TCIM
42
TIAA CREF Investment Management
New York
$2.31M -$187K -11,915 -6%
Acadian Asset Management
43
Acadian Asset Management
Massachusetts
$2.2M +$2.58M +164,613 New
HI
44
HBK Investments
Texas
$2.16M +$2.53M +161,800 New
Russell Investments Group
45
Russell Investments Group
United Kingdom
$2.15M +$2.22M +142,012 +749%
PAMU
46
Pictet Asset Management (UK)
United Kingdom
$1.99M +$330K +21,100 +16%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$1.78M -$100K -6,400 -5%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$1.74M -$89.3K -5,700 -4%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$1.72M +$581K +37,076 +40%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.71M -$92.4K -5,900 -4%
1
2
3 4 5

MNTA Hedge Fund Activity: Q1 2017 in Review

162 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2017, worth a combined $873M — down 9.3% from $962M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MNTA positions and 18 closed out — a net gain of 7 holders — while 64 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Discovery Capital Management, cutting an estimated $22.7M.

  • 162 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2017, up from 160 in Q4 2016.
  • Funds reported $873M of Momenta Pharmaceuticals, Inc. stock for Q1 2017, down 9.3% quarter-over-quarter.
  • 25 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2017 and 18 closed out, a net change of +7 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $137M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q1 2017 was Discovery Capital Management, an estimated $22.7M sold.

Based on aggregated 13F filings for Q1 2017.